JHEP Reports
Издатель: Elsevier · ISSN 2589-5559 · 80 статей
- Sleep and Sedentary Behavior Predict Severity in MASLD but Not MetALD/ALD: A Compositional Analysis
- From histology to VCTE-based treatment selection in MASLD: Beyond biopsy-selected cohorts
- Rapid genetic testing and treatment of patients with severe and early onset intrahepatic cholestasis of pregnancy
- Reply to: “From snapshot to trajectory: verified breath alcohol monitoring as a direct, measurable marker of drinking in at-risk populations”
- Risk of Adverse Kidney Outcomes in Families with MASLD: A Population-Based Multigenerational Cohort Study
- Patient-Derived Organoids from cryopreserved tissue can represent clinically relevant tools for drug testing in Biliary Cancer
- Postmenopausal estradiol levels and female sex modulate haemodynamic responsiveness in experimental portal hypertension
- A protein modification of TIGAR Fuels HCC Growth by Boosting Tumor Glucose Metabolism
- Myeloid Suppressor Cells Drive HCC Invasiveness via the THBS1–SDC4 Pathway
- Spatiotemporal Multi-Omics Reveals Primate-Specific Mechanisms of Liver Regeneration Following Partial Hepatectomy
- Editorial Board page
- Contents
- Gender differences in stigma and care avoidance among people living with MASLD: An international survey
- Targeting circulating fatty acid-binding protein 4 ameliorates obesity-associated hepatic steatosis
- Integrative multi-omics analysis identifies stellate cell-derived complement component 7 as a predictor of fibrosis and liver-related events in MASLD
- The circadian clock controls hepatic inflammation in MASLD
- Therapeutic vaccination strategy targeting the PreS1 region of L-HBsAg for HBV/HDV co-infection
- Sleep irregularity is associated with reduced wellbeing in patients with cirrhosis
- First decompensation outweighs portal vein thrombosis in cACLD: Molecular profiling and derivation of the VAIL score
- Risk prediction models for hepatic encephalopathy post-transjugular intrahepatic portosystemic shunt: A systematic review and critical appraisal
- Diverging trends and persistent inequities in cirrhosis burden across sub-Saharan Africa: Projections to 2040
- PD-1+ TIGIT+ HLA-DR+ CD38+ CD8 T cells as surrogate markers of liver antigen reactivity in active autoimmune hepatitis
- Ubiquitin-Mediated Loss of PDCD4 Promotes Progression of Intrahepatic Cholangiocarcinoma
- Linked deletions in BCP and preS1 enhance HBV replication
- Management of rare primary liver cancers: Combined hepato-cholangiocarcinoma and fibrolamellar hepatocellular carcinoma
- Clinico-radiological differences between porto-sinusoidal vascular disorder and cirrhosis
- Atezolizumab–bevacizumab with or without cisplatin-based HAIC for unresectable HCC: A randomized phase II trial
- SREBP-driven lipogenesis coupled with ferroptosis resistance as a therapeutic target in PTEN-loss extrahepatic cholangiocarcinoma
- Systemic treatment patterns and clinical outcomes in hepatocellular carcinoma: A multicenter real-world study from China (STAR-HCC)
- Integrative multi-omics identifies cholangiolocarcinoma as a distinct molecular subtype of intrahepatic cholangiocarcinoma